Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level

Jocelin Huang, Ayalew Tefferi

Research output: Contribution to journal › Letter › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level'. Together they form a unique fingerprint.